Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1682
    +0.0026 (+0.22%)
     
  • GBP/USD

    1.2493
    -0.0018 (-0.14%)
     
  • Bitcoin GBP

    51,153.49
    -754.95 (-1.45%)
     
  • CMC Crypto 200

    1,330.91
    -65.62 (-4.70%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.67
    +0.10 (+0.12%)
     
  • GOLD FUTURES

    2,349.10
    +6.60 (+0.28%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

European Market for Dental Soft Tissue Regeneration 2020-2026 with COVID-19 Impact Analysis

Dublin, Nov. 06, 2020 (GLOBE NEWSWIRE) -- The "Dental Soft Tissue Regeneration Market Report Suite with COVID Impact - Europe - 2020-2026 - MedCore" report has been added to ResearchAndMarkets.com's offering.

This report is a comprehensive analysis of a group of healthcare markets. This MedCore is one portion of that analysis which focuses on the Dental Soft Tissue Regeneration market segment and provides detailed analysis on the Market Size, Unit Sales, ASPs, and Company Market Shares.

Dental Soft Tissue Regeneration Market Insights

The vast majority of unit sales were xenograft products produced by Geistlich and Botiss, and the remainder consisted mostly of AlloDerm, which is distributed by BioHorizons. Even if regulations surrounding the use of human tissue for soft tissue regeneration impede sales of these types of products throughout Europe, within the dental indication specifically, the regulatory hurdles are slightly less pronounced.

Some dentists in this market are using these devices to increase biotype and soft tissue thickness around implants. The number of dental regenerative matrix units sold is partly correlated with the number of dental implant procedures in a given country. This explains why, population differences aside, unit sales in Germany and Italy were slightly higher than in France, and significantly higher than in the United Kingdom.

The EU dental soft tissue regeneration market was valued at €7.3 million in 2019. The market value is expected to increase and reach somewhere in between €8.5 and €9.9 million by 2026, depending on the impact of COVID-19 on the overall market.

Key Topics Covered:

LIST OF FIGURES

LIST OF CHARTS

RESEARCH METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

PROCEDURE NUMBERS

IMPACT OF COVID-19 ON THE EUROPE DENTAL SOFT TISSUE REGENERATION MARKET
3.1 INTRODUCTION
3.2 MULTI-SCENARIO ANALYSIS

EUROPE DENTAL SOFT TISSUE REGENERATION MARKET
4.1 INTRODUCTION
4.2 MARKET ANALYSIS AND FORECAST
4.3 DRIVERS AND LIMITERS
4.4 COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

Companies Mentioned

  • Botiss Biomaterials

  • Geistlich

  • Allergan

  • Orthocell

  • Zimmer Biomet

For more information about this report visit https://www.researchandmarkets.com/r/tmpf0z

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ADVERTISEMENT

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900